Resultados de la búsqueda 101-110 of 3201 for Assay

  1. Oncología (médica) - Ensayos clínicos

    Eligible participants with mCRC will be enrolled into specific treatment arms based on their biomarker assay results. ... assays and results from a ctDNA assay by ...

  2. Oncología (médica) - Ensayos clínicos

    Circulating Tumor DNA (cTDNA) Based in NGS (Next Generation Sequencing) Assays for Oncology Patients With Solid Tumors ... assays and results from a ctDNA assay ...

  3. Oncología (médica) - Ensayos clínicos

    Rochester, Minn. The purpose of this study is to compare whether minimal residual disease (MRD) flow cytometric assay is not affected by different ...

  4. Oncología (médica) - Ensayos clínicos

    The purpose of ORACLE is to demonstrate the ability of a novel ctDNA assay developed by Guardant Health to detect recurrence in individuals treated for early- ...

  5. Oncología (médica) - Ensayos clínicos

    ... assay for the detection of mutations associated with uveal melanoma. The performance characteristics of the ddPCR assay for the detection of ctDNA mutation ...

  6. Oncología (médica) - Ensayos clínicos

    Rochester, Minn. The purpose of this study is to compare whether minimal residual disease (MRD) flow cytometric assay is not affected by different ...

  7. Oncología (médica) - Ensayos clínicos

    The purpose of ORACLE is to demonstrate the ability of a novel ctDNA assay developed by Guardant Health to detect recurrence in individuals treated for early- ...

  8. Oncología (médica) - Ensayos clínicos

    The purpose of ORACLE is to demonstrate the ability of a novel ctDNA assay developed by Guardant Health to detect recurrence in individuals treated for early- ...

  9. Enfermedades infecciosas - Ensayos clínicos - Mayo Clinic

    Laboratory Assay Optimization 2.0. Rochester, Minn. The purpose of this study is to better understand the role of HIV and/or HCV infection and/or SARS-CoV-2 ...

  10. Oncología (médica) - Ensayos clínicos

    Rochester, Minn. The purpose of this study is to compare whether minimal residual disease (MRD) flow cytometric assay is not affected by different ...